Cat. #156515
Anti-RILP [BBRILP36.1]
Cat. #: 156515
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Rab-interacting lysosomal protein
Class: Monoclonal
Application: IF ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: A*STAR Accelerate Technologies Pte Ltd
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-RILP [BBRILP36.1]
- Alternate name: RILP
- Cancer: Breast cancer
- Cancers detailed: Breast cancer
- Research fields: Metabolism
- Tool sub type: Primary antibody
- Class: Monoclonal
- Purpose: Marker
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: IF ; WB
- Description: Rabs are a large family of small GTPases best known for their involvement in intracellular membrane trafficking. When activated, Rabs recruit their effectors to membrane compartments to exert diverse functions such as sorting of cargo into budding vesicles, vesicle movement along the cytoskeleton and tethering and fusion to target membranes. Functional impairments of Rabs or their accessory proteins are manifested in a range of diseases including neurological disorders and diabetes as well as in infectious diseases. RILP (Rab interacting lysosomal protein) was first identified as a Rab7 effector. By binding to the dynein motor complexes, RILP promotes microtubule-mediated transport of Rab7-positive late endosomes and lysosomes away from the cell periphery and toward the nucleus. Interestingly, RILP also acts as an effector for the predominantly Golgi-localized Rab34. The Rab34/RILP association, which presumably is taking place at the Golgi appears to control the distant lysosomal distribution. Important note: several lines of publicly available data indicate low and very restricted expression of RILP in immortalized cell lines as well as in tissues.
- Immunogen: Bacterially expressed C-terminal half of human RILP. The details of the immunogen are proprietary.
- Isotype: IgG2a kappa
- Myeloma used: Sp2/0
- Recommended controls: Hela
Target Details
- Target: Rab-interacting lysosomal protein
- Target background: Rabs are a large family of small GTPases best known for their involvement in intracellular membrane trafficking. When activated, Rabs recruit their effectors to membrane compartments to exert diverse functions such as sorting of cargo into budding vesicles, vesicle movement along the cytoskeleton and tethering and fusion to target membranes. Fn impairments of Rabs or their accessory proteins are manifested in a range of diseases including neurological disorders and diabetes as well as in infe...
Applications
- Application: IF ; WB
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Shipping at 4° C